Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential.

Serotype III group B streptococcus (GBS) causes more invasive disease in infants than do other serotypes in North America. We used multilocus sequence typing to identify clones within 28 invasive serotype III GBS isolates identified from a population-based study and 55 serotype III GBS colonizing isolates from a cohort of women from the same population. Ten allelic sequence types (STs) were identified and primarily involved 2 profiles: ST-19 (57.1% of invasive isolates and 58.2% of colonizing isolates) and ST-17 (32.1% of invasive isolates and 29.1% of colonizing isolates). On concatenation, the 10 allelic profiles converged into 3 groups. Group 1 consisted of ST-19 complex, ST-36, and ST-1, and was closely related to reference genome 2603V/R (serotype V). Group 2 consisted of ST-17 complex. Group 3 consisted of ST-23 complex and was closely related to the serotype III genome strain NEM 316. Neither of the major sequence types or groups was more commonly associated with invasion (P=.61) or with lower levels of maternal capsular polysaccharide-specific IgG (0.89 microg/mL and 0.39 microg/mL, respectively) for ST-19 and ST-17 (P=.86). The close association of genomic strain 2603V/R (serotype V) with ST-19 suggests that the phenomenon of capsule switching may have occurred.

[1]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[2]  C. Baker,et al.  Group B streptococcal conjugate vaccines , 2003, Archives of disease in childhood.

[3]  Carmen Buchrieser,et al.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.

[4]  Ian T. Paulsen,et al.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Meng-Yao Liu,et al.  Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Todd M. Smith,et al.  Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Davies,et al.  Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. , 2001, The Pediatric infectious disease journal.

[8]  C. Adair,et al.  Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.

[9]  L. Hammitt,et al.  Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. , 2001, The Journal of infectious diseases.

[10]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Holt,et al.  Neonatal meningitis in England and Wales: 10 years on , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[12]  H. Yim,et al.  The Serotype of Type Ia and III Group B Streptococci Is Determined by the Polymerase Gene within the Polycistronic Capsule Operon , 2000, Journal of bacteriology.

[13]  J. M. Smith,et al.  Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. , 2000, Genetics.

[14]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[15]  B. Spratt,et al.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. , 2000, Journal of clinical microbiology.

[16]  B. Spratt,et al.  multilocus sequence typing , 2017 .

[17]  B. Spratt.  Multilocus sequence typing: molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the internet. , 1999, Current opinion in microbiology.

[18]  H. Davies,et al.  The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. , 1999, Paediatrics & child health.

[19]  B. Spratt,et al.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. , 1998, Microbiology.

[20]  E. Adderson,et al.  Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. , 1998, The Journal of infectious diseases.

[21]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Kilian,et al.  Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease , 1996, Infection and immunity.

[23]  D. Morse,et al.  Neonatal meningitis in England and Wales: a review of routine national data , 1994, Archives of disease in childhood. Fetal and neonatal edition.

[24]  R. Hurley,et al.  Infantile meningitis in England and Wales: a two year study. , 1991, Archives of disease in childhood.

[25]  A. Hightower,et al.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.

[26]  J. Musser,et al.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Kasper,et al.  Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. , 1980, The New England journal of medicine.

[28]  D. Kasper,et al.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.

[29]  F. Barrett,et al.  Group B streptococcal infections in infants. The importance of the various serotypes. , 1974, JAMA.